<DOC>
	<DOCNO>NCT01435200</DOCNO>
	<brief_summary>Can intravenous iron low rate blood transfusion gynecologic cancer patient receive platinum base chemotherapy oral iron ?</brief_summary>
	<brief_title>Intravenous Iron Gynecologic Cancer Patients Receiving Chemotherapy</brief_title>
	<detailed_description>Anemia common condition chemotherapy administration . Treatment option usually include oral iron supplementation blood transfusion . However , oral iron gastrointestinal side effect , affect patient compliance , small amount oral iron absorb gastrointestinal tract . Intravenous iron may overcome block iron absorption iron recycle induced hepcidin . Therefore , may increase hemoglobin level reduce blood transfusion cancer patient receive chemotherapy .</detailed_description>
	<mesh_term>Iron</mesh_term>
	<criteria>Age 2070 year Good performance status ( Zubrod score &lt; 2 ) No serious underlying disease Normal renal function test Normal liver function test Platinum base chemotherapy first line regimen No prior receive radiotherapy Iron hypersensitivity Underlying disease risk iron overload chronic kidney disease , major thalassemia Progressive disease Bone marrow metastasis</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Intravenous iron</keyword>
	<keyword>gynecologic cancer blood transfusion</keyword>
</DOC>